HIGHLIGHTS
- who: Benjamin C. Conner from the This protocol was approved by the Northern Arizona University Institutional Review Board (#986744) and completed at the Northern Arizona University-Phoenix Biomedical Campus (Phoenix, AZ)The protocol utilized participants recruited for a clinical trial, which was prospectively registered at(NCT04119063). Prior to starting the study, informed written consent was provided by each participant if , years or older, or the parent/legal guardian in the case of minors (minors also provided verbal assent). Participant inclusion criteria was as follows: confirmed diagnosis of CP (hemi- or diplegic distributions), Gross Motor Function Classification System . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.